Cleared Traditional

K220349 - TeraRecon Neuro (FDA 510(k) Clearance)

Aug 2022
Decision
186d
Days
Class 2
Risk

K220349 is an FDA 510(k) clearance for the TeraRecon Neuro. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Terarecon,Inc. (Durham, US). The FDA issued a Cleared decision on August 12, 2022, 186 days after receiving the submission on February 7, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K220349 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 2022
Decision Date August 12, 2022
Days to Decision 186 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050